Document is current
Any future updates will be listed below
-
Authors
Grippin, Adam J. https://orcid.org/0000-0002-8076-4240
Marconi, Christiano
Copling, Sage
Li, Nan
Braun, Chen
Woody, Cole https://orcid.org/0009-0000-3441-8446
Young, Elliana
Gupta, Priti
Wang, Min
Wu, Annette
Jeong, Seong Dong
Soni, Dhruvkumar
Weidert, Frances
Xie, Chao
Goldenberg, Eden
Kim, Andrew
Zhao, Chong
DeVries, Anna
Castillo, Paul
Lohray, Rishabh
Rooney, Michael K.
Schrank, Benjamin R. https://orcid.org/0000-0001-8138-4250
Wang, Yifan https://orcid.org/0000-0001-7387-0654
Ma, Yifan https://orcid.org/0000-0002-9371-4365
Chang, Enoch
Kouzy, Ramez
Dyson, Kyle https://orcid.org/0000-0002-7972-3249
Jafarnia, Jordan https://orcid.org/0000-0001-7195-9882
Nariman, Nina https://orcid.org/0009-0000-0069-6966
Gladish, Gregory
New, Jacob https://orcid.org/0000-0003-0707-9324
Argueta, Ada
Amaya, Diana
Thomas, Nagheme
Doty, Andria
Chen, Joe
Copling, Nikhil
Alatrash, Gabriel https://orcid.org/0009-0000-8443-3150
Simon, Julie
Davies, Alicia Bea
Dennis, William
Liang, Richard
Lewis, Jeff
Wei, Xiong
Rinsurongkawong, Waree
Vaporciyan, Ara A.
Johns, Andrew
,
Aaroe, Ashley
Abraham, Sanu
Andrews, Lee II
Badami, Kiran K.
Baganz, Janna A.
Bajwa, Pratibha
Barbosa, Gregory R.
Beird, Hannah C.
Brock, Kristy
Burton, Elizabeth M.
Cata, Juan
Chung, Caroline
Claussen, Catherine
Crommett, John
Cutherell, Michael
Dabaja, Bouthaina
Dagher, Hiba
Daniels, Kevin M.
Domask, Mary
Draetta, Giulio
Edelkamp, Paul Jr
Fisher, Sarah
French, Katy Elizabeth
Futreal, Andrew
Gaeta, Maria
Godoy, Myrna
Goldstein, Drew
Gunther, Jillian
Hutcheson, Kate
Jaffray, David
Jin, Jeff
John, Teny Matthew
Kell, Trey
Knafl, Mark
Kwan, Rayson C.
Lee, J. Jack
Litton, Jennifer
McEnery, Kevin W.
McGuire, Mary
Mescher, Benjamin
Musunuru, Tejo
Muthu, Mayoora
Nates, Joseph
Owen, Craig S.
Padmakumar, Priyadharshini
Palaskas, Nicholas
Patel, Jay J.
Prabhakaran, Sabitha
Ramsey, Lucas
Ravi, Vinod
Hernandez, Cristhiam Rojas
Sajith, Bilja
Scheet, Paul A.
Schmidt, Stephanie
Shaw, Kenna R.
Shete, Sanjay
Shoenthal, Daniel P.
Stoltenberg, Lessley J.
Tawbi, Hussein
Turin, Anastasia
Unni, Samir
Vicknamparampil, Benju
Weber, Max C.
Weinstein, John
Woodman, Scott Eric
Wozny, Mark C.
Wu, Carol
Wu, Jia
Yao, James C.
Young, Chingyi
Yu, Emily
Zatorski, Steven
Aloia, Thomas A.
Trujillo, John Cuenca
Gibbons, Christopher
Kothari, Anai
Subbiah, Ishwaria
Thompson, Phillip
Lee, Jack https://orcid.org/0000-0001-5469-9214
Lee, Ji-Hyun https://orcid.org/0000-0001-6420-5150
Sun, Ryan https://orcid.org/0000-0003-1176-1561
Sharma, Padmanee https://orcid.org/0000-0003-4658-055X
Tran, Hai
Zhang, Jianjun https://orcid.org/0000-0001-7872-3477
Gibbons, Don L. https://orcid.org/0000-0003-2362-3094
Wargo, Jennifer https://orcid.org/0000-0003-3438-7576
Kim, Betty Y. S. https://orcid.org/0000-0001-6890-8355
Heymach, John V. https://orcid.org/0000-0001-9068-8942
Mendez-Gomez, Hector R.
Jiang, Wen https://orcid.org/0000-0001-9154-633X
Sayour, Elias J. https://orcid.org/0000-0002-5309-3197
Lin, Steven H. https://orcid.org/0000-0003-4411-0634
- License Information
-
More Information
Article History
Received: 6 November 2024
Accepted: 19 September 2025
First Online: 22 October 2025
Change Date: 5 November 2025
Change Type: Update
Change Details: In the version of the article initially published, the text “ B.R.S. is a CPRIT Scholar in Cancer Research, RR250092” was missing from the Acknowledgements section and has now been added to the HTML and PDF versions of the article.
Competing interests
: A.J.G. has received travel funding from Alamar Biosciences and is a scientific advisor for Sift Biosciences and BeyondSpring Pharmaceuticals. J.Z. reports grants from Merck, grants and personal fees from Johnson & Johnson and Novartis, personal fees from Bristol Myers Squibb, AstraZeneca, GenePlus, Innovent and Hengrui outside the submitted work. D.L.G. is a scientific advisor for AstraZeneca, Eli Lilly, Menarini Richerche, 4D Pharma, Onconova Therapeutics and Sanofi. P.S. is on the scientific advisory committee for Achelois, Affini-T, Akoya Biosciences, Apricity, Asher Bio, BioAtla LLC, Candel Therapeutics, Catalio, C-Reveal Therapeutics, Dragonfly Therapeutics, Earli Inc, Enable Medicine, Henlius/Hengenix, Hummingbird, ImaginAb, InterVenn Biosciences, LAVA Therapeutics, Lytix Biopharma, Marker Therapeutics, Matrisome, Oncolytics, Osteologic, PBM Capital, Phenomic AI, Polaris Pharma, Soley Therapeutics, Spotlight, Trained Therapeutix Discovery, Two Bear Capital and Xilis, Inc., and reports private investments in Adaptive Biotechnologies, BioNTech, JSL Health, Sporos and Time Bioventures. S.H.L. receives grant funding from Beyond Spring Pharmaceuticals and Nektar Therapeutics, serves on the scientific advisory boards for Beyond Spring Pharmaceuticals, AstraZeneca and Creatv Microtech, and is co-founder of and holds stock options in Seek Diagnostics. J.V.H. reports being on advisory committees for BioNTech, Genentech, Mirati Therapeutics, Eli Lilly, Janssen, Boehringer Ingelheim, Regeneron, Takeda, BerGenBio, Jazz, Curio Science, Novartis, AstraZeneca, BioAlta, Sanofi, Spectrum, GlaxoSmithKline, EMD Serono, BluePrint Medicine and Chugai; support from AstraZeneca, Boehringer Ingelheim, Spectrum, Mirati, Bristol Myers Squibb and Takeda; and licensing or royalties from Spectrum. E.J.S. is a paid consultant for Siren Biotechnology, an external advisory board member at Nature’s Toolbox (NTX) with stock options, and a scientific advisor for iOncologi, Inc. The Article discusses patented technologies related to RNA therapeutics from A.J.G., C.M., S.H.L, D.S., H.R.M.-G. and E.J.S. Some of these technologies are licensed or under option to license by iOncologi, Inc. H.R.M.-G. and E.J.S. receive royalty payments from patents licensed to iOncologi. The other authors declare no competing interests.
